Resource Tracking

Latest report available:

Capitalizing on Scientific Progress: Investment in HIV Prevention R&D in 2010

AVAC serves as the secretariat for the HIV Vaccines and Microbicides Resource Tracking Working Group, which also includes the International AIDS Vaccine Initiative, IPM, the International Partnership for Microbicides and UNAIDS. This year's new report along with archives of the Working Group's previous reports can be found at www.hivresourcetracking.org.

Also available:

An Exploratory Analysis of HIV Treatment Research and Development Investments in 2009

To measure progress and assess whether funding levels are adequate and properly invested in the most promising science, the Treatment Action Group and AVAC sought to document the world’s investment in developing new or enhancing existing HIV therapeutic regimens and strategies by examining R&D spending and establish an investment baseline, starting with the year 2009.

The report, An Exploratory Analysis of HIV Treatment Research and Development Investments in 2009, found that 48 funders worldwide (of 144 surveyed) reported investing $US 2.46 billion across six HIV-related research categories—basic science, drug discovery and development, operational and implementation science, antiretroviral prevention, applied/infrastructure and HIV diagnostics.